MYO5B and paraganglioma: MYO5B expression was reported to be upregulated in pheochromocytoma and paraganglioma tissues, and MYO5B mutation (p.L587P, p.G1611S, and p.R1641C) was demonstrated to be responsible for cancer cell proliferation and migration [11].